IREN stock dropped despite strong AI growth and platform progress. Learn about its revenue shifts, debt strategy, and future ...
AlphaFold didn't accelerate biology by running faster experiments. It changed the engineering assumptions behind protein ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a foc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback